A

Achilles Therapeutics PLC
NASDAQ:ACHL

Watchlist Manager
Achilles Therapeutics PLC
NASDAQ:ACHL
Watchlist
Price: 1.48 USD 0.68% Market Closed
Market Cap: 60.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ACHL.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACHL Intrinsic Value
Not Available
Base Case Scenario
Compare ACHL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ACHL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Achilles Therapeutics PLC

Current Assets 111.6m
Cash & Short-Term Investments 86.1m
Receivables 637k
Other Current Assets 24.9m
Non-Current Assets 11.1m
PP&E 9.2m
Other Non-Current Assets 1.8m
Current Liabilities 18.5m
Accounts Payable 4.2m
Accrued Liabilities 13m
Other Current Liabilities 1.2m
Non-Current Liabilities 1.1m
Other Non-Current Liabilities 1.1m
Efficiency

Free Cash Flow Analysis
Achilles Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Achilles Therapeutics PLC

Revenue
0 USD
Operating Expenses
-72m USD
Operating Income
-72m USD
Other Expenses
5.2m USD
Net Income
-66.9m USD
Fundamental Scores

ACHL Profitability Score
Profitability Due Diligence

Achilles Therapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Achilles Therapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ACHL Solvency Score
Solvency Due Diligence

Achilles Therapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Achilles Therapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACHL Price Targets Summary
Achilles Therapeutics PLC

There are no price targets for ACHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Achilles Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for ACHL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y